Newer anticonvulsants in the treatment of anxiety disorders
Information
- DOI:
- https://doi.org/10.1002/14651858.CD006241Copy DOI
- Database:
-
- Cochrane Database of Systematic Reviews
- Version published:
-
- 18 October 2006see what's new
- Type:
-
- Intervention
- Stage:
-
- Protocol
- Cochrane Editorial Group:
-
Cochrane Common Mental Disorders Group
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Article metrics
Altmetric:
Cited by:
Authors
Contributions of authors
Jonathan Ipser compiled the background and method sections of the protocol. Dan Stein assisted in this process, and also served as a coordinator for the protocol.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
MRC Research Unit on Anxiety and Stress Disorders, Cape Town, South Africa.
Declarations of interest
The MRC Anxiety and Stress Disorders Research Unit has received funding from almost all pharmaceutical companies involved with psychiatry in South Africa.
Potential conflict of interest for individual reviewers
Jonathan Ipser has no known conflict of interest outside of his employment by the MRC Unit on Anxiety and Stress Disorders.
Dan Stein has received research grants and/or consultancy honoraria from Astrazeneca, Eli‐Lilly, GlaxoSmithKline, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, and Wyeth. He has participated in a number of ongoing trials, and has presented data from some of these trials on behalf of the sponsoring companies.
Acknowledgements
The authors are supported by the MRC Research Unit on Anxiety and Stress Disorders (Cape Town, South Africa).
Version history
| Published | Title | Stage | Authors | Version |
| 2006 Oct 18 | Newer anticonvulsants in the treatment of anxiety disorders | Protocol | Jonathan C Ipser, Dan J Stein | |
